A chimaeric llβ-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Glucocorticoid-remediable aldosteronism (GRA), an autosomal dominant disorder, is characterized by hypertension with variable hyperaldosteronism and by high levels of the abnormal adrenal steroids 18-oxocortisol and 18-hydroxycortisol, which are all under control of adrenocorticotropic hormone and suppressible by glucocorticoids. These abnormalities could result from ectopic expression of aldosterone synthase, which is normally expressed only in adrenal glomerulosa, in the adrenal fasciculata. Genes encoding aldosterone synthase and steroid 11 beta-hydroxylase (expressed in both adrenal fasciculata and glomerulosa), which are 95% identical and lie on chromosome 8q (refs 7, 10), are therefore candidate genes for GRA. Here we demonstrate complete linkage of GRA in a large kindred to a gene duplication arising from unequal crossing over, fusing the 5' regulatory region of 11 beta-hydroxylase to the coding sequences of aldosterone synthase (maximum lod score 5.23 for complete linkage, odds ratio of 170,000:1). This mutation can account for all the physiological abnormalities of GRA. Our result represents the demonstration of a mutation causing hypertension in otherwise phenotypically normal animals or humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consistent with a tandem duplication event, the two human genes are closely linked, separated by 40 kb, exhibiting similar intron/exon structure, and 90 and 95% identity in the coding and non-coding sequences, respectively (59, 70).”
From Adrenal Mitochondria and Steroidogenesis: From Individual Proteins to Functional Protein Assemblies (2016) · cites this paper as [70]
In the citing paper
“Although gene conversion events in the CYP11B locus are rare, an unusual gene duplication, caused by unequal crossing over between the CYP11B1 and CYP11B2 genes, results in glucocorticoid-remediable aldosteronism (GRA) (490 -492).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [490]
In the citing paper
“The crossover results in one allele having a third, hybrid CYP11B gene in which the ACTHregulated promoter and the first few exons of CYP11B1 are fused in frame to most of the exons of CYP11B2, resulting in the zona fasciculata expression of a chimeric protein with aldosterone synthase activity (490, 491) (Fig. 12).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [490]
In the citing paper
“They are particularly important in patients in glucocorticoid remediable aldosteronism or with aldosterone-producing adenomas associated with KCNJ5 mutations [261,[264], [265], [266], [267], [268], [269], [270], [271], [272]].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [264]
In the citing paper
“Urinary excretion of aldosterone metabolites is increased (Fig. 6) (115, 124), with the urinary (18OHF+18oxoF)/THAldo ratio further supporting diagnosis (116); the urinary metabolite 18oxoTHF (Fig. 7) is characteristically increased.”
From Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism (2019) · cites this paper as [124]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,887
Orita, M., Suzuki, Y., Sekiya, T., & Hayashi, K. (1989) · Genomics · doi:10.1016/0888-7543(89)90129-8 · Cited by 3,434
Hypertension : pathophysiology, diagnosis, and management
Laragh, J. H., & Brenner, B. M. (1995) · Raven Press eBooks · Cited by 1,932
Gilliland, G., Perrin, S., Blanchard, K., & Bunn, H. F. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.7.2725 · Cited by 1,454
Hypertension: Pathophysiology, Diagnosis, and Management
White, W. B. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03460110128039 · Cited by 944
Polymorphic DNA region adjacent to the 5' end of the human insulin gene.
Bell, G. I., Karam, J. H., & Rutter, W. J. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.9.5759 · Cited by 889
Regulation of the synthesis of steroidogenic enzymes in adrenal cortical cells by ACTH
Simpson, E. R., & Waterman, M. R. (1988) · Annual Review of Physiology · doi:10.1146/annurev.ph.50.030188.002235 · Cited by 506
Sutherland, D. J., Ruse, J. L., & Laidlaw, J. C. (1966) · PubMed Central · Cited by 467
Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta).
Mornet, É., Dupont, J., Vitek, A., & White, P. C. (1989) · PubMed · Cited by 440
Characterization of Two Genes Encoding Human Steroid 11β-Hydroxylase (P-45011β)
Mornet, E., Dupont, J., Vitek, A., & White, P. C. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)30030-4 · Cited by 405
Research works printed but not linked: 2
- Sutherland, D. J., Ruse, J. L. & Laidlaw, J. C. Can. med. Assoc. J. 95, 1109–1119 (1966).
- Pickering, G. W. in The Epidemiology of Hypertension (eds Stamler, J., Stamler, R. & Pullman, T. N.) 18–27 (Grune & Stratton, New York, 1967).
Cited by
Items 401–500 of 995
Blood pressure and human genetic variation in the general population
Arora, P. K., & Newton‐Cheh, C. (2010) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3283383e2c · Cited by 39
Treatment of primary aldosteronism
Quinkler, M. O., & Stewart, P. M. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.10.001 · Cited by 38
Mulatero, P., Williams, T. A., Milan, A., Paglieri, C., Rabbia, F., Fallo, F., & Veglio, F. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.7.8666 · Cited by 43
Sugiyama, T., Kato, N., Ishinaga, Y., Yamori, Y., & Yazaki, Y. (2001) · Hypertension Research · doi:10.1291/hypres.24.515 · Cited by 36
Mineralocorticoid receptors in the central nervous system
Funder, J. W. (1996) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00235-9 · Cited by 37
Hyperaldosteronism: recent concepts, diagnosis, and management
Foo, R., O’Shaughnessy, K. M., & Brown, M. J. (2001) · Postgraduate Medical Journal · doi:10.1136/pmj.77.912.639 · Cited by 32
Guo, Z., Nanba, K., Udager, A. M., McWhinney, B. C., Ungerer, J. P. J., Wolley, M. J., Thuzar, M., Gordon, R. D., Rainey, W. E., & Stowasser, M. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa367 · Cited by 34
Studies on the Origin of Circulating 18-Hydroxycortisol and 18-Oxocortisol in Normal Human Subjects
Freel, E. M., Shakerdi, L. A., Friel, E. C., Wallace, A. M., Davies, E., Fraser, R., & Connell, J. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0379 · Cited by 34
Steroidogenesis in Aldosterone-Producing Adenoma Revisited by Transcriptome Analysis
Assié, G., Auzan, C., Gasc, J., Baviéra, E. E., Balaton, A. J., Elalouf, J., Jeunemaître, X., Plouin, P., Corvol, P. L., & Clauser, É. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1309 · Cited by 35
Freel, E. M., Ingram, M. C., Friel, E. C., Fräser, R., Mj, B., Samani, N. J., Caulfield, M. J., Munroe, P. B., Farrall, M., Webster, J., et al. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02971.x · Cited by 35
Familial Forms Broaden the Horizons for Primary Aldosteronism
Gordon, R. D., & Stowasser, M. (1998) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(98)00058-7 · Cited by 33
Isolated congenital ACTH deficiency: a cleavage enzyme defect?
Soo, S. C., Bain, M. D., Gibson, S., White, A. E., Johnstone, A. P., & Nussey, S. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02499.x · Cited by 32
The molecular basis of primary aldosteronism: from chimeric gene to channelopathy
Lenzini, L., & Rossi, G. P. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.12.005 · Cited by 33
Endocrine Hypertension: Then and Now
Young, W. F. (2010) · Endocrine Practice · doi:10.4158/ep10205.ra · Cited by 33
Clinical and Molecular Perspectives of Monogenic Hypertension
Levanovich, P., Diaczok, A., & Rossi, N. F. (2019) · Current Hypertension Reviews · doi:10.2174/1573402115666190409115330 · Cited by 37
Ménard, J., & Pascoe, L. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000226183.98439.b3 · Cited by 33
Investigating mineralocorticoid hypertension
Nussberger, J. (2003) · Journal of Hypertension · doi:10.1097/00004872-200305002-00005 · Cited by 34
Pathophysiology, Evaluation, and Medical Management of Adrenal Disorders
Kutikov, A., Crispen, P. L., & Uzzo, R. G. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6911-9.00057-8 · Cited by 34
Disordered zonal and cellular CYP11B2 enzyme expression in familial hyperaldosteronism type 3
Gómez-Sánchez, C. E., Qi, X., Gómez-Sánchez, E. P., Sasano, H., Bohlen, M. O., & Wisgerhof, M. V. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.10.025 · Cited by 31
The 103I Variant of the Melanocortin 4 Receptor Is Associated with Low Serum Triglyceride Levels
Brönner, G., Sattler, A., Hinney, A., Soufi, M., Geller, F., Schäfer, H., Maisch, B., Hebebrand, J., & Schaefer, J. R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0919 · Cited by 34
Pathophysiology of adrenal hypertension
Moneva, M. H., & Gómez-Sánchez, C. E. (2002) · Seminars in Nephrology · doi:10.1053/snep.2002.28670 · Cited by 32
Chronic mineralocorticoid excess and cardiovascular remodeling
Weber, K. T., Sun, Y., Campbell, S. E., Slight, S. H., Ganjam, V. K., Griffing, G. T., Swinfard, R. W., & Diaz‐Arias, A. A. (1995) · Steroids · doi:10.1016/0039-128x(94)00030-g · Cited by 31
Stowasser, M., Gordon, R. D., Klemm, S. A., & Tunny, T. J. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.3.800 · Cited by 31
Williams, R. R., Hunt, S. C., Hopkins, P. N., Wu, L., & Lalouel, J. M. (1994) · Clinical Genetics · doi:10.1111/j.1399-0004.1994.tb04207.x · Cited by 31
Self-citationVariation of phenotype in patients with glucocorticoid remediable aldosteronism.
Gates, L. J., MacConnachie, A., Lifton, R. P., Haites, N. E., & Benjamin, N. (1996) · Journal of Medical Genetics · doi:10.1136/jmg.33.1.25 · Cited by 31
Self-citationTherapeutic relevance of pharmacogenetic factors in cardiovascular medicine
Nakagawa, K., & Ishizaki, T. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00066-2 · Cited by 31
Perez‐Rivas, L. G., Williams, T. A., & Reincke, M. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0713-0629 · Cited by 38
Fischer, E., Beuschlein, F., Degenhart, C., Jung, P., Bidlingmaier, M., & Reincke, M. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04243.x · Cited by 31
Primary aldosteronism: emerging trends
Galati, S.-J., Hopkins, S. M., Cheesman, K. C., Zhuk, R. A., & Levine, A. C. (2013) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2013.05.003 · Cited by 37
The molecular basis of blood pressure variation
Toka, H. R., Koshy, J. M., & Hariri, A. (2012) · Pediatric Nephrology · doi:10.1007/s00467-012-2206-9 · Cited by 32
Diagnosis of Diseases of Steroid Hormone Production, Metabolism and Action
Honour, J. W. (2009) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.v1i5.209 · Cited by 32
Diagnosis of hypokalemia: a problem-solving approach to clinical cases.
Assadi, F. K. (2008) · Iranian Journal of Kidney Diseases · Cited by 30
Af17 Deficiency Increases Sodium Excretion and Decreases Blood Pressure
Chen, L., Wu, H., Pochynyuk, O. M., Reisenauer, M. R., Zhang, Z., Huang, L., Zaika, O., Mamenko, M., Zhang, W., Zhou, Q., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010121270 · Cited by 30
Genetic rat models of hypertension: Relationship to human hypertension
Stoll, M., & Jacob, H. J. (2001) · Current Hypertension Reports · doi:10.1007/s11906-001-0031-9 · Cited by 30
Pascoe, L., & Curnow, K. M. (1995) · Steroids · doi:10.1016/0039-128x(94)00003-u · Cited by 31
History of Adrenal Research: From Ancient Anatomy to Contemporary Molecular Biology
Miller, W. L., & White, P. C. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac019 · Cited by 35
Diagnosis and treatment of primary aldosteronism
Mulatero, P., Monticone, S., & Veglio, F. (2011) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-011-9156-6 · Cited by 33
Evaluation of primary aldosteronism
Mulatero, P., Monticone, S., Bertello, C., Tizzani, D., Iannaccone, A., Crudo, V. L., & Veglio, F. (2010) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283390f8d · Cited by 30
Monogenic forms of low-renin hypertension: clinical and molecular insights
Khandelwal, P., & Deinum, J. (2021) · Pediatric Nephrology · doi:10.1007/s00467-021-05246-x · Cited by 34
PLASMA ALDOSTERONE RESPONSE TO ACTH IN SUBTYPES OF PRIMARY ALDOSTERONISM
Stowasser, M., Klemm, S. A., Tunny, T. J., & Gordon, R. D. (1995) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1995.tb02044.x · Cited by 29
Hyperaldosteronism: primary versus tertiary
Stowasser, M. (2002) · Journal of Hypertension · doi:10.1097/00004872-200201000-00004 · Cited by 30
Association between Aldosterone Production and Variation in the 11β-Hydroxylase (CYP11B1) Gene
Imrie, H., Freel, M., Mayosi, B. M., Davies, E., Fraser, R., Ingram, M. C., Cordell, H. J., Farrall, M., Avery, P. J., Watkins, H. C., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1481 · Cited by 29
Aldosterone synthase (CYP11B2) polymorphisms and cardiovascular function
White, P. C., Hautanen, A., & Kupari, M. M. (1999) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(99)00071-0 · Cited by 29
Pathogenesis of Familial Hyperaldosteronism Type II: New Concepts Involving Anion Channels
Stowasser, M., Wolley, M. J., Wu, A., Gordon, R. D., Schewe, J., Stölting, G., & Scholl, U. I. (2019) · Current Hypertension Reports · doi:10.1007/s11906-019-0934-y · Cited by 34
Pathophysiology of Hypertension
Yamaguchi, I., & Flynn, J. T. (2009) · Springer eBooks · doi:10.1007/978-3-540-76341-3_61 · Cited by 30
McBride, M., McVie, A. J., Burridge, S. M., Brintnell, B., Craig, N., Wallace, A. M., Wilson, R. H., Varley, J. M., & Sutcliffe, R. (1999) · Genomics · doi:10.1006/geno.1999.5459 · Cited by 34
CYP11B2 polymorphisms and cardiovascular risk factors
Davies, E., & Kenyon, C. J. (2003) · Journal of Hypertension · doi:10.1097/00004872-200307000-00008 · Cited by 30
Genetic Factors in Hypertension – What is Known and What Does It Mean?
Melander, O. (2001) · Blood Pressure · doi:10.1080/080370501753400575 · Cited by 34
Rapid diagnosis of glucocorticoid suppressible hyperaldosteronism in infants and adolescents.
Jamieson, A., Inglis, G., Campbell, M., Fräser, R., & Connell, J. (1994) · Archives of Disease in Childhood · doi:10.1136/adc.71.1.40 · Cited by 31
Characterizing the Origins of Primary Aldosteronism
Brown, J. M., Honzel, B., Tsai, L. C., Milks, J., Neibuhr, Y., Newman, A. J., Cherney, M. D., Stouffer, D. G., Auchus, R. J., & Vaidya, A. (2024) · Hypertension · doi:10.1161/hypertensionaha.124.24153 · Cited by 34
A clinical approach to tubulopathies in children and young adults
Kermond, R., Mallett, A. J., & McCarthy, H. J. (2022) · Pediatric Nephrology · doi:10.1007/s00467-022-05606-1 · Cited by 28
Spyroglou, A., Bozoglu, T. M., Rawal, R., Leonardis, F. D., Sterner, C. W., Boulkroun, S., Benecke, A., Monti, L., Zennaro, M., Petersen, A.-K., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02504 · Cited by 28
The Adrenal Cortex and Its Disorders
Miller, W. L., Achermann, J. C., & Flück, C. E. (2008) · Elsevier eBooks · doi:10.1016/b978-141604090-3.50017-x · Cited by 33
Genetic Polymorphisms of Angiotensinogen and Essential Hypertension in a Tibetan Population
Niu, W., Qi, Y., Cen, W.-J., Cui, C., Zhuoma, C., Cai, D., Zhou, W., & Qiu, C. (2007) · Hypertension Research · doi:10.1291/hypres.30.1129 · Cited by 28
Molecular biology of 11β-hydroxylase and 11β-hydroxysteroid dehydrogenase enzymes
White, P. C., Pascoe, L., Curnow, K. M., Tannin, G. M., & Rösler, A. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90309-7 · Cited by 30
Staermose, S., Marwick, T. H., Gordon, R. D., Cowley, D., Dowling, A., & Stowasser, M. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.128512 · Cited by 28
Carvajal, C. A., Campino, C., Martínez‐Aguayo, A., Tichauer, J. E., Bancalari, R. E., Valdivia, C. P., Trejo, P., Marlene Aglony, I., Baudrand, R. F., Lagos, C. F., et al. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.180513 · Cited by 28
A multilocus approach to the antihypertensive pharmacogenetics of hydrochlorothiazide
Maitland-van der Zee, A.-H., Turner, S. T., Schwartz, G. L., Chapman, A. B., Klungel, O. H., & Boerwinkle, E. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01213011-200505000-00003 · Cited by 28
Wu, K., Chen, Y., Chu, S., Hung, K., Hsieh, T. S., & Hsieh, B. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.3.7883831 · Cited by 27
Hypertension and adrenal disorders
Chemaitilly, W., Wilson, R. C., & New, M. I. (2003) · Current Hypertension Reports · doi:10.1007/s11906-003-0058-1 · Cited by 28
Ouabainlike Compound in Hypertension Associated With Ectopic Corticotropin Syndrome
Goto, A., Yamada, K., Hazama, H., Uehara, Y., Atarashi, K., Hirata, Y., Kimura, K., & Omata, M. (1996) · Hypertension · doi:10.1161/01.hyp.28.3.421 · Cited by 28
Genetic disorders of steroid hormone synthesis and metabolism
New, M. I., & White, P. C. (1995) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(95)80587-7 · Cited by 35
Cook, D. M. (1997) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70284-x · Cited by 36
Overview of Monogenic Forms of Hypertension Combined With Hypokalemia
Lu, Y., Fan, P. T., Zhang, D., Zhang, Y., Meng, X., Zhang, Q.-Y., Zhao, L. Y., Yang, K., & Zhou, X. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2020.543309 · Cited by 30
New advances in endocrine hypertension: from genes to biomarkers
Fernandes-Rosa, F. L., Boulkroun, S., Fedlaoui, B., Hureaux, M., Travers, S. A. A., Drossart, T., Favier, J., & Zennaro, M. (2023) · Kidney International · doi:10.1016/j.kint.2022.12.021 · Cited by 32
Elevated blood pressure and cardiac hypertrophy after ablation of thegly96/IEX-1gene
Sommer, S. L., Berndt, T. J., Frank, E., Patel, J., Redfield, M. M., Dong, X., Griffin, M. D., Grande, J. P., van Deursen, J. M. A., Sieck, G. C., et al. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00306.2005 · Cited by 27
Familial or Genetic Primary Aldosteronism and Gordon Syndrome
Stowasser, M., Pimenta, E., & Gordon, R. D. (2011) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2011.01.007 · Cited by 26
Mullins, L. J., Kenyon, C. J., Bailey, M. A., Conway, B. R., Díaz, M. E., & Mullins, J. J. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05262 · Cited by 34
Rösler, A., & White, P. C. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90128-j · Cited by 28
New Causes of Cushing's Syndrome
BERTAGNA, X. Y. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210013271410 · Cited by 27
1-deoxysphingolipids bind to COUP-TF to modulate lymphatic and cardiac cell development
Wang, T., Wang, Z., de Fabritus, L., Tao, J., Saied, E. M., Lee, H., Ramazanov, B. R., Jackson, B., Burkhardt, D. B., Parker, M., et al. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.10.018 · Cited by 24
Fujii, W., & Shibata, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097719 · Cited by 31
Aldosteronomas—State of the Art
McKenzie, T. J., Lillegard, J. B., Young, W. F., & Thompson, G. B. (2009) · Surgical Clinics of North America · doi:10.1016/j.suc.2009.06.017 · Cited by 28
Genetic epidemiology of hypertension: an update on the African diaspora.
Daniel, H. I., & Rotimi, C. N. (2003) · PubMed · Cited by 26
Influence of heredity on human sensitivity to environmental chemicals
Weber, W. W. (1995) · Environmental and Molecular Mutagenesis · doi:10.1002/em.2850250614 · Cited by 28
Bechtel, S., Belkina, N., & Bernhardt, R. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.02729.x · Cited by 30
Kidney-specific chromosome transfer in genetic hypertension: The Dahl hypothesis revisited
Churchill, P. C., Churchill, M. C., BIDANI, A. K., & Kurtz, T. W. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.060002705.x · Cited by 26
Inherited Disorders of the Renal Tubule
Bonnardeaux, A., & Bichet, D. G. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10044-2 · Cited by 23
The Genetic Basis of Primary Aldosteronism
Funder, J. W. (2012) · Current Hypertension Reports · doi:10.1007/s11906-012-0255-x · Cited by 28
Medeau, V., Assié, G., Zennaro, M., Clauser, É., Plouin, P. F., & Jeunemaı̂tre, X. (2005) · Annales d Endocrinologie · doi:10.1016/s0003-4266(05)81756-1 · Cited by 25
Fisher, A., Friel, E. C., Bernhardt, R., Gómez-Sánchez, C. E., Connell, J., Fraser, R., & Davies, E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7797 · Cited by 25
Clinical manifestation of aldosteronoma
Fehaily, M. A., & Duh, Q. (2004) · Surgical Clinics of North America · doi:10.1016/j.suc.2004.02.001 · Cited by 25
Ferrari, P., Obeyesekere, V. R., Li, K., Andrews, R. K., & Krozowski, Z. S. (1996) · Steroids · doi:10.1016/0039-128x(96)00013-x · Cited by 27
HYPERTENSION: Matching the right drug to the right patient in essential hypertension
Mj, B. (2001) · Heart · doi:10.1136/heart.86.1.113 · Cited by 29
Update on Genetics of Primary Aldosteronism
Itcho, K., Oki, K., Ohno, H., & Yoneda, M. (2021) · Biomedicines · doi:10.3390/biomedicines9040409 · Cited by 25
Pizzolo, F., Trabetti, E., Guarini, P., Mulatero, P., Ciacciarelli, A., Blengio, G., Corrocher, R., & Olivieri, O. (2005) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001821 · Cited by 27
Willenberg, H. S., Späth, M. R., Maser‐Gluth, C., Engers, R., Anlauf, M., Dekomien, G., Schott, M., Schinner, S., Cupisti, K., & Scherbaum, W. A. (2010) · Hypertension Research · doi:10.1038/hr.2010.18 · Cited by 27
Integrating Genetics and Genomics in Primary Aldosteronism
Zennaro, M., Jeunemaître, X., & Boulkroun, S. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.188250 · Cited by 27
Feldman, R. D. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01251 · Cited by 29
Yu, H., LIN, S., LIU, G., Zhang, Y., MA, W., & Deng, C. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.02.007 · Cited by 24
REGULATION OF ALDOSTERONE BIOSYNTHESIS: THE END OF THE ROAD?
Müller, J. (1998) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1998.tb02306.x · Cited by 31
Kennon, B., Ingram, M. C., Friel, E. C., Anderson, N., MacKenzie, S. M., Davies, E., Shakerdi, L. A., Wallace, A. M., Fraser, R., & Connell, J. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02073.x · Cited by 24
ALDOSTERONE ACTION: FACT, FAILURE AND THE FUTURE
Funder, J. W. (1998) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1998.tb02300.x · Cited by 24
Transgenic animals in the study of blood pressure regulation and hypertension
Thompson, M. W., Merrill, D., Yang, G., Robillard, J., & Sigmund, C. D. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.269.5.e793 · Cited by 25
A primer on the genetics of hypertension
Cusi, D., & Bianchi, G. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00007.x · Cited by 26
Hübner, N., Kreutz, R. H., Takahashi, S., Ganten, D., & Lindpaintner, K. (1994) · Hypertension · doi:10.1161/01.hyp.23.6.797 · Cited by 24
Lim, S. (2007) · PubMed · Cited by 23
Genetic Disorders of Potassium Homeostasis
Jain, G., Ong, S., & Warnock, D. G. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2013.04.010 · Cited by 23
L- and T-type calcium channels control aldosterone production from human adrenals
Yang, T., He, M., Zhang, H., Barrett, P. Q., & Hu, C. (2019) · Journal of Endocrinology · doi:10.1530/joe-19-0259 · Cited by 26
Glucocorticoid-remediable aldosteronism
McMahon, G. T., & Dluhy, R. G. (2004) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302004000500014 · Cited by 23
Self-citation
Metadata
- Authors
- Lifton, R. P., Dluhy, R. G., Powers, M., Rich, G. M., Cook, S., Ulick, S., & Lalouel, J.-M.
- Affiliations
- Howard Hughes Medical Institute (US)
- Brigham and Women's Hospital (US)
- Veterans Health Administration (US)
- ORCID
- Lifton, Richard P.
- Venue
- Nature
- Published
- 1992-01
- Volume
- 355
- Issue
- 6357
- Pages
- 262-265
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1979069430
- Semantic Scholar
- 48f7453ea9e77a6f893ab90603be6343f5cad138
- Cited by
- 1,158
- References
- 23
- Citations by year
- 2026: 18 · 2025: 10 · 2024: 21 · 2023: 37 · 2022: 29 · 2021: 26 · 2020: 25 · 2019: 24 · 2018: 36 · 2017: 35 · 2016: 30 · 2015: 34 · 2014: 34 · 2013: 36 · 2012: 32
- FWCI
- 30.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Keywords
- glucocorticoid-remediable aldosteronism, aldosterone synthase, 11β-hydroxylase, fusion genes, gene duplication, unequal crossover, hypertension, hyperaldosteronism, 18-oxocortisol, 18-hydroxycortisol, ACTH, chromosome 8q, genetic linkage, autosomal dominant disorder, adrenal glomerulosa
- MeSH terms
- Base Sequence, Chimera, Crossing Over, Genetic, Cytochrome P-450 Enzyme System, Exons, Female, Humans, Hyperaldosteronism, Hypertension, Introns, Male, Molecular Sequence Data, Oligodeoxyribonucleotides, Pedigree, Steroid Hydroxylases, Steroid 11-beta-Hydroxylase, Polymerase Chain Reaction, Cytochrome P-450 CYP11B2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.